In June 2011, the U.S. Food & Drug Administration (FDA) issued a Drug Safety Communication warning that men taking Finasteride may face a higher risk of developing high-grade prostate cancer. At the time, the FDA mandated that the labels for Finasteride medications be updated to warn of this risk. Additionally, in August 2011, the Canadian Health Agency, stated that male breast cancer has been reported in a small number of patients worldwide with both the 1 mg and 5 mg formulations of finasteride, though most have been associated with the 5mg formulation.
Keep sucking down that poison.
Keep sucking down that poison.
Comment